SEC Form 4 · accession 0001209191-15-050508
Axogen, Inc. · AXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph M Mandato
Director
Period of report
Jun 3, 2015
Accepted (ET)
Jun 5, 2015 · 3:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000805928
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 3, 2015 | P | 6,500 | $3.10 | A | 50,000 | D | |
| Common StockF1 | holding | — | — | — | 1,376,392 | I | see footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares are owned by De Novo Ventures II, L.P. ("DNV II"). De Novo Management II, LLC is the sole general partner of DNV II. The reporting person is a managing member of De Novo Management II, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.